Durect Corp. diskutieren
Durect Corp.
WKN: 564868 / Symbol: DRRX / Name: DURECT / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,37 €
-8,04 %
DURECT Co. (NASDAQ: DRRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at Northland Securities. They set an "outperform" rating on the stock.
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for DRRX provided by MarketBeat
DURECT Co. (NASDAQ: DRRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $5.00 price target on the stock.
Ratings data for DRRX provided by MarketBeat
Neueste Beiträge
Telsey_Advisory_Grou in Abercrombie + Fitch A diskutieren, Abercrombie + Fitch A